Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study
about
How I treat acquired aplastic anemiaImmunosuppressive therapy for transplant-ineligible aplastic anemia patients.Horse antithymocyte globulin as salvage therapy after rabbit antithymocyte globulin for severe aplastic anemia.Prolonged cyclosporine administration after antithymocyte globulin delays but does not prevent relapse in severe aplastic anemia.Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine.Moderate-dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution.Recent advances in treatment of aplastic anemia.Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia.Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials NeFirst-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapyDecreased infection-related mortality and improved survival in severe aplastic anemia in the past two decades.SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes.Granulocyte transfusion combined with granulocyte colony stimulating factor in severe infection patients with severe aplastic anemia: a single center experience from China.Clinical management of aplastic anemia.Safety and efficacy of indigenous equine antithymocyte globulin along with cyclosporine in subjects with acquired aplastic anemia.Immunosuppressive therapy in patients with aplastic anemia: a single-center retrospective study.Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemiaAplastic anemia: pathophysiology and treatment.Presentation and Management of Paroxysmal Nocturnal Hemoglobinuria: A Single-Center Experience.Success of allogeneic marrow transplantation for children with severe aplastic anaemia.Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia.Horse versus rabbit antithymocyte globulin in acquired aplastic anemiaFinal results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndromeTreatment of refractory or relapsed acquired aplastic anemia: review of established and experimental approaches.Aplastic anemia: immunosuppressive therapy in 2010.Antibodies in the treatment of aplastic anemia.How I manage aplastic anaemia in children.Front-line immunosuppressive treatment of acquired aplastic anemia.Alternative immunosuppression in patients failing immunosuppression with ATG who are not transplant candidates: Campath (Alemtuzumab).Management of acquired aplastic anemia in children.The optimal immunosuppressive therapy for aplastic anemia.Sirolimus-based immunosuppression as GVHD prophylaxis after bone marrow transplantation for severe aplastic anaemia: a case report and review of the literatureCurrent management of severe acquired aplastic anemia.Therapy for aplastic anemia.Rapamycin targets several pathophysiological features of immune-mediated bone marrow failure in murine models.Rapamycin is highly effective in murine models of immune-mediated bone marrow failure.Immune suppression for childhood acquired aplastic anemia and myelodysplastic syndrome: where next?Immunosuppressive treatment for aplastic anemia: are we hitting the ceiling?The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.Expression of IL-27, Th1 and Th17 in patients with aplastic anemia.
P2860
Q24617687-CA4ED78E-425B-43D2-82CE-1A68CD628B96Q33419679-8719A12D-D193-4C77-BD66-525563160F1FQ33757965-D8162A41-3265-495B-B756-F728B19B8368Q33820120-07AA7CA5-B4CF-4155-B724-0369F6FC937DQ33952747-36CE6C74-846D-425C-A2DA-9484A69ED553Q34431435-D0FB82E8-5DE7-4289-BF45-8CCF56B6CCA7Q34451351-F4863AE5-8070-4807-A362-8573C1F949F0Q34555435-A99D354F-0566-45A4-B3FA-99B34158823DQ34645147-88AB1DB1-6B95-4650-A3E2-16ED99B79C50Q34649082-3A1D77DB-D223-468C-9269-13CB8408FE5CQ35019920-99CD5D7D-512B-443B-839C-A1B5A2886FF1Q35083258-DEAC71DB-13F4-4C85-B399-DA86E0B44A82Q35088529-98BD36F1-D43A-4AF2-9562-A2F326174D12Q35112372-79503DE5-B20F-4976-BE2E-1CCE66DB1802Q35220764-F810C230-84CD-4B5C-A907-FBE5F0A352DCQ35602992-E0387CEA-2C2F-49A2-9321-077A5E6957C9Q35669193-4665149C-1497-47B2-BC48-CB117B8A3106Q36464602-84DF1B2B-FE94-410A-8BBF-35414EAB83F7Q36751227-DAE034AB-C46B-46BF-8177-B0F18668F9A4Q36958013-20BE77FC-EA3E-450D-9607-C39DED8D7592Q37040876-D408DA74-7DEE-4CA9-B4BD-3BEDD1F06DA2Q37040881-A36B825F-B0F6-40D3-8193-3EE6BEE3BA57Q37584833-2FB67ACF-03BF-474F-9653-65AA93F8A4DAQ37884078-E776A153-565E-45B2-926B-12488C595A5EQ37952705-F3E7D510-E9D4-4B0C-9729-4E68EF948540Q37981576-B76420E2-5CEE-41D2-B10C-6DF7BBCAB7EBQ37986162-35B67304-5A22-46A3-8CAA-B8D0F704D027Q38061040-423C2759-89BC-472C-AF12-47B5093141EEQ38065877-060C8537-5BDC-4D5D-91C1-8E3BA61E1114Q38071931-14AB3957-C9FA-41BA-B204-4ED98004852AQ38100685-80596627-41C9-4EDC-A5CA-ED2BD2E1EE18Q38335265-3E7DF4D9-16D8-46FC-8995-89CA242ABD33Q38694686-53EAC963-5FBA-4514-9FE8-885B8E2A5654Q41992063-BB177C29-7E95-4259-8250-1D8C975500B9Q42368313-AF5DA5A5-CB92-4A83-9F0B-104AA259AE03Q42368320-7CFFE0A8-6580-4E72-AEA9-9DA3F54B4C56Q42385120-3AAEDE77-20C9-440B-A591-18471EC6821DQ43171570-DCEFA858-618A-45F3-946B-1D50510CD026Q44434880-A0CC6D68-5F50-4D1F-B928-B37024EE7B56Q44955344-DDFC033E-D502-4C31-B725-73A705D12106
P2860
Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of severe aplastic a ...... a prospective randomized study
@en
Treatment of severe aplastic a ...... prospective randomized study.
@nl
type
label
Treatment of severe aplastic a ...... a prospective randomized study
@en
Treatment of severe aplastic a ...... prospective randomized study.
@nl
prefLabel
Treatment of severe aplastic a ...... a prospective randomized study
@en
Treatment of severe aplastic a ...... prospective randomized study.
@nl
P2093
P2860
P356
P1433
P1476
Treatment of severe aplastic a ...... a prospective randomized study
@en
P2093
Carol Boss
Colin O Wu
Elaine M Sloand
Neal S Young
Olga Nunez
Phillip Scheinberg
Priscila Scheinberg
P2860
P304
P356
10.3324/HAEMATOL.13829
P577
2009-01-30T00:00:00Z